 DRAPER, Utah, Feb. 16, 2021 GLOBE NEWSWIRE -- HealthEquity, Inc. NASDAQ: HQY HealthEquity or the Company, today announced the pricing of the previously announced underwritten public offering of 5 million shares of its common stock. BofA Securities may offer the shares of common stock from time to time to purchasers directly or through agents, or through brokers in brokerage transactions on the NASDAQ, or in the over-the-counter market, or to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. Gross proceeds to HealthEquity from the offering, before underwriting discounts and commissions, are expected to be 401.5 million. The offering is expected to close on February 19, 2021, subject to customary closing conditions. Additionally, HealthEquity has granted BofA Securities a 30-day option to purchase up to an additional 750,000 shares of its common stock. HealthEquity intends to use the net proceeds from this offering for potential acquisitions, repayment of indebtedness and other general corporate purposes. 